Analytical Data
-
Gene name
SSNA1
- Application
-
Alternative Names
SSNA1；NA14；Microtubule nucleation factor SSNA1
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O43805
-
Expression Region
2-119aa
-
AA Sequence
TQQGAALQNYNNELVKCIEELCQKREELCRQIQEEEDEKQRLQNEVRQLTEKLARVNENLARKIASRNEFDRTIAETEAAYLKILESSQTLLSVLKREAGNLTKATAPDQKSSGGRDS
-
Molecular Weight
17.0 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SSNA1 (Suppressor of SIpv1, Nedd4-Associated 1) is a protein that has garnered attention in the field of molecular biology due to its role in various cellular processes, including signal transduction and regulation of protein degradation. Research has shown that SSNA1 is involved in the modulation of cell growth and differentiation, particularly in cells subjected to stress conditions. It is also implicated in the regulation of the epithelial-mesenchymal transition (EMT), which is a crucial process in development and cancer metastasis. Understanding the structure and function of SSNA1, particularly through the study of its recombinant protein form, is essential for elucidating its biological roles and potential therapeutic applications. The production of recombinant SSNA1 has facilitated detailed studies on its interaction with other cellular proteins, its post-translational modifications, and its impact on specific signaling pathways. This research is critical as it may reveal novel insights into the mechanisms underlying diseases, such as cancer, and could lead to the development of targeted therapies. Furthermore, as SSNA1 has been associated with various pathological conditions, including neurodegenerative diseases and cancer, exploring its properties at the protein level may provide new avenues for drug discovery and therapeutic innovation. Overall, the study of SSNA1 recombinant proteins is a promising area of research that holds the potential to advance our understanding of complex cellular mechanisms and contribute to the development of new medical interventions.
